ZA81136B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA81136B
ZA81136B ZA00810136A ZA81136A ZA81136B ZA 81136 B ZA81136 B ZA 81136B ZA 00810136 A ZA00810136 A ZA 00810136A ZA 81136 A ZA81136 A ZA 81136A ZA 81136 B ZA81136 B ZA 81136B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA00810136A
Inventor
J Lampard
J Dunn
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of ZA81136B publication Critical patent/ZA81136B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
ZA00810136A 1980-01-11 1981-01-09 Pharmaceutical compositions ZA81136B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (1)

Publication Number Publication Date
ZA81136B true ZA81136B (en) 1982-01-27

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00810136A ZA81136B (en) 1980-01-11 1981-01-09 Pharmaceutical compositions

Country Status (22)

Country Link
JP (1) JPS56103110A (en)
AT (1) AT374681B (en)
AU (1) AU542824B2 (en)
BE (1) BE886998A (en)
CA (1) CA1140466A (en)
CH (1) CH646604A5 (en)
DE (1) DE3100191A1 (en)
DK (1) DK6181A (en)
ES (2) ES8205353A1 (en)
FI (1) FI76927C (en)
FR (1) FR2473308B1 (en)
GB (1) GB2067072B (en)
GR (1) GR73843B (en)
IE (1) IE50806B1 (en)
IN (1) IN151913B (en)
IT (1) IT1221041B (en)
LU (1) LU83052A1 (en)
NL (1) NL8100037A (en)
NO (1) NO156153C (en)
NZ (1) NZ195933A (en)
SE (1) SE447450B (en)
ZA (1) ZA81136B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (en) * 1981-03-19 1986-10-29 Pharmatec Spa CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN
JPS59227817A (en) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd Long-acting bredinin preparation for oral administration
JPH0662404B2 (en) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド Controlled-release naproxen and naproxen sodium tablets
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
DE3688188T2 (en) * 1985-12-27 1993-10-14 Sumitomo Pharma Process for the preparation of a sustained release formulation.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
NZ223619A (en) * 1987-02-27 1990-10-26 Lilly Co Eli Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL128902C (en) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
DE3100191A1 (en) 1981-12-10
AT374681B (en) 1984-05-25
IT1221041B (en) 1990-06-21
ES509179A0 (en) 1982-12-16
GB2067072A (en) 1981-07-22
DE3100191C2 (en) 1988-09-01
FI810056L (en) 1981-07-12
JPS56103110A (en) 1981-08-18
CA1140466A (en) 1983-02-01
IT8147537A0 (en) 1981-01-09
NO156153C (en) 1987-08-05
ATA5481A (en) 1983-10-15
NO810062L (en) 1981-07-13
DK6181A (en) 1981-07-12
AU542824B2 (en) 1985-03-14
ES498369A0 (en) 1982-06-01
NZ195933A (en) 1982-11-23
IN151913B (en) 1983-09-03
GB2067072B (en) 1983-08-10
FI76927C (en) 1989-01-10
IE50806B1 (en) 1986-07-23
GR73843B (en) 1984-05-07
FI76927B (en) 1988-09-30
IE810036L (en) 1981-07-11
LU83052A1 (en) 1982-09-10
CH646604A5 (en) 1984-12-14
ES8301629A1 (en) 1982-12-16
ES8205353A1 (en) 1982-06-01
NL8100037A (en) 1981-08-03
SE447450B (en) 1986-11-17
NO156153B (en) 1987-04-27
BE886998A (en) 1981-07-08
AU6597681A (en) 1981-07-16
FR2473308A1 (en) 1981-07-17
FR2473308B1 (en) 1985-07-19
SE8100104L (en) 1981-07-12

Similar Documents

Publication Publication Date Title
ZA813465B (en) Pharmaceutical composition
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA824622B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA825397B (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
ZA822856B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
IL62432A (en) Pharmaceutical compositions based on sulphonamide-potentiator combinations
PT73952B (en) Pharmaceutical compositions
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
HK91387A (en) Pharmaceutical compositions
ZA826479B (en) Pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
ZA815175B (en) Pharmaceutical composition